Shahid Adangam Purath, Sasidharan Nanu, Salini Sasidharan, Padikkala Jose, Meera Nair, Raghavamenon Achuthan Chathrattil, Babu Thekkekara Devassy
Department of NTFP, Kerala Forest Research Institute, Peechi, Thrissur, Kerala, India.
Department of Biochemistry, Amala Cancer Research Centre, Amala Nagar, Thrissur, Kerala, India.
J Tradit Complement Med. 2017 Jun 26;8(1):244-250. doi: 10.1016/j.jtcme.2017.06.005. eCollection 2018 Jan.
(Fabaceae) is a prime ingredient in , a well-known Ayurvedic preparation for gynecological ailments. Due to scarcity, adulteration or substitution of related raw drugs is a common practice in its preparation. The bark of (Roxb. ex DC.) Harms, morphologically similar to (Asoka) is a widely used substitute. The present study aimed to evaluate the pharmacological effectiveness of as an alternative for in by determining the inhibitory effect of estrogen induced uterus endometrial thickening in immature female rats. was prepared using and with the substitute, as per Ayurvedic Pharmacopeia. Uterus endometrial thickening was induced by the administration of estradiol (20 μg/kg b. wt, i.p) to 8-day-old rats for 5 alternate days. On day 16, following estradiol administration, the serum estrogen level was found elevated to 156.5 ± 8 pg/ml from the normal value 32.4 ± 5 pg/ml and consequently increased the thickness of uterus endometrium from 16.7 ± 1.4 to 75.2 ± 15.3 μm. Upon oral administration of 400 μl/kg b. wt (ASA) and made with (AKP), the thickening was reduced to 42.5 ± 12.7 and 47.1 ± 10.5 μm and the estrogen level diminished to 102.6 ± 10 and 97.3 ± 8 pg/ml, respectively. also reduced the chronic/acute inflammations in mice and improved the antioxidant status of rats. No toxic symptom was observed in the animals by the treatment of . The study supports the use of as an alternative to in and gives a scientific validation for in gynecological ailments.
(豆科)是[某种药物名称]的主要成分,[某种药物名称]是一种著名的用于治疗妇科疾病的阿育吠陀制剂。由于原料稀缺,在其制备过程中,相关原料药的掺假或替代是常见做法。[植物名称1](Roxb. ex DC.)Harms的树皮在形态上与[植物名称2](阿育王树)相似,是一种广泛使用的替代品。本研究旨在通过测定雌激素诱导的未成熟雌性大鼠子宫内膜增厚的抑制作用,评估[植物名称1]作为[植物名称2]在[某种药物名称]中的替代品的药理有效性。按照阿育吠陀药典,使用[植物名称2]和替代品[植物名称1]制备[某种药物名称]。给8日龄大鼠腹腔注射雌二醇(20μg/kg体重),隔日注射,共5次,诱导子宫内膜增厚。在第16天,给予雌二醇后,血清雌激素水平从正常值32.4±5pg/ml升高至156.5±8pg/ml,子宫内膜厚度从16.7±1.4μm增加至75.2±15.3μm。口服400μl/kg体重的[植物名称2]提取物(ASA)和用[植物名称1]制备的提取物(AKP)后,增厚分别降至42.5±12.7μm和47.1±10.5μm,雌激素水平分别降至102.6±10pg/ml和97.3±8pg/ml。[植物名称2]提取物还减轻了小鼠的慢性/急性炎症,并改善了大鼠的抗氧化状态。经[植物名称2]提取物处理后,动物未观察到毒性症状。该研究支持在[某种药物名称]中使用[植物名称1]替代[植物名称2],并为其在妇科疾病中的应用提供了科学验证。